Compare GNLX & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNLX | INVE |
|---|---|---|
| Founded | 2001 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.4M | 80.1M |
| IPO Year | 2023 | 1997 |
| Metric | GNLX | INVE |
|---|---|---|
| Price | $4.17 | $3.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $19.75 | $5.50 |
| AVG Volume (30 Days) | ★ 157.5K | 48.2K |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $22,015,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.82 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.99 | $2.86 |
| 52 Week High | $8.54 | $4.07 |
| Indicator | GNLX | INVE |
|---|---|---|
| Relative Strength Index (RSI) | 35.32 | 53.79 |
| Support Level | $4.00 | $3.40 |
| Resistance Level | $4.37 | $3.79 |
| Average True Range (ATR) | 0.32 | 0.14 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 13.94 | 61.65 |
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.